Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,454 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,230 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00121212 | Positron Emission Tomography in Prostate Cancer | completed | N/A | 179 | Washington University School of MedicineOTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00853697 | Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | completed | Phase 2 | 6 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 30, 2015 | clinicaltrials |
| NCT01915316 | Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy | completed | — | 30 | ProSightINDUSTRY | 1 | Oct 29, 2015 | clinicaltrials |
| NCT02102646 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | completed | Phase 4 | 31 | Herlev HospitalOTHER | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00560482 | Efficacy Study of ABR-215050 to Treat Prostate Cancer | completed | Phase 2 | 206 | Active Biotech ABINDUSTRY | 3 | Oct 26, 2015 | clinicaltrials |
| NCT00872157 | BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00574899 | Prostate Biomarker Study | completed | — | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00685646 | Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases(ZAPCA) | completed | Phase 3 | 227 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00763152 | CMT-07-08: The PROstate Bed Evaluation Study | completed | — | 12 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT01501630 | Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer(FLUPROSTIC) | completed | — | 112 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT01229618 | Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer | completed | Phase 1 | 31 | University of California, San FranciscoOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT00905086 | Psychosocial Adjustment After Radiation Therapy in Patients With Cancer | completed | — | 80 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01511874 | Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer | completed | Phase 4 | 42 | HanAll BioPharma Co., Ltd.INDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01656161 | Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer | completed | Phase 3 | 120 | Debiopharm International SAINDUSTRY | 1 | Sep 15, 2015 | clinicaltrials |
| NCT00818480 | An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 | completed | Phase 2 | 10 | Astellas Pharma IncINDUSTRY | 1 | Sep 4, 2015 | clinicaltrials |
| NCT02437539 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography(uPAR-PET) | completed | Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Aug 24, 2015 | clinicaltrials |
| NCT00777959 | Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002) | completed | Phase 2 | 22 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 19, 2015 | clinicaltrials |
| NCT01215526 | A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer(FAST-NL) | completed | — | 274 | Ferring PharmaceuticalsINDUSTRY | 1 | Aug 19, 2015 | clinicaltrials |
| NCT01897207 | Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 15 | Cantonal Hospital of St. GallenOTHER | 0 | Aug 17, 2015 | clinicaltrials |
| NCT00514267 | An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors | completed | Phase 1 / Phase 2 | 32 | Astellas Pharma IncINDUSTRY | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01621425 | Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity(LEANDOC) | completed | — | 25 | Radboud University Medical CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01658319 | Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies | completed | Phase 1 | 20 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | completed | Early Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01011751 | Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma | completed | Phase 3 | 311 | TakedaINDUSTRY | 1 | Jul 30, 2015 | clinicaltrials |
| NCT02149628 | The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide | completed | Phase 4 | 50 | Yonsei UniversityOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT01546623 | A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy | completed | Phase 3 | 160 | TakedaINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00936975 | Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01320735 | Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia | completed | — | 300 | AbbVie (prior sponsor, Abbott)INDUSTRY | 0 | Jul 8, 2015 | clinicaltrials |
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT00108732 | A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jun 30, 2015 | clinicaltrials |
| NCT01482741 | Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging | completed | — | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT00327288 | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients | completed | Phase 1 | 34 | AmpliMed CorporationINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT00058539 | Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer | completed | Phase 2 | 42 | Genentech, Inc.INDUSTRY | 0 | Jun 23, 2015 | clinicaltrials |
| NCT01599182 | Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer | completed | — | 9 | University of WaterlooOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01744366 | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population(PANDA) | completed | Phase 3 | 285 | Ferring PharmaceuticalsINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01857908 | A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Jun 22, 2015 | clinicaltrials |
| NCT00708968 | Prostate Cancer: Family Care for Patients and Spouses | completed | N/A | 263 | University of MichiganOTHER | 1 | Jun 16, 2015 | clinicaltrials |
| NCT00830635 | Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | completed | N/A | 1,800 | University of Colorado, DenverOTHER | 1 | Jun 16, 2015 | clinicaltrials |
| NCT01415089 | Tailored Web-Based Intervention for Cancer Patients and Family Caregivers(FOCUS-WEB) | completed | N/A | 63 | University of MichiganOTHER | 1 | Jun 16, 2015 | clinicaltrials |
| NCT00720135 | Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma | completed | Phase 1 | 9 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01277562 | Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer | completed | — | 56 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01954004 | Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients | completed | — | 1,270 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jun 2, 2015 | clinicaltrials |
| NCT02460549 | Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation(Nutriprophy) | completed | N/A | 9 | Institut de Cancérologie de la LoireOTHER | 1 | Jun 2, 2015 | clinicaltrials |
| NCT00743379 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 71 | Threshold PharmaceuticalsINDUSTRY | 1 | May 7, 2015 | clinicaltrials |
| NCT01526486 | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | completed | N/A | 29 | Emory UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00692653 | Personal Patient Profile Prostate (P4) Randomized, Multisite Trial(P4) | completed | N/A | 498 | Dana-Farber Cancer InstituteOTHER | 1 | May 4, 2015 | clinicaltrials |
| NCT00715104 | Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer(NeoACT) | completed | Phase 2 | 42 | DendreonINDUSTRY | 1 | May 4, 2015 | clinicaltrials |
| NCT00900185 | Study of a Polymorphism in Patients With Prostate Cancer | completed | — | 750 | National Cancer Institute (NCI)NIH | 0 | Apr 30, 2015 | clinicaltrials |
| NCT00019110 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Oct 30, 2015source: clinicaltrials